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Abstract
The exposure of the body to stress, 
regardless of whether it comes from physical, 
chemical or emotional stimuli from the 
environment, causes an inadequate adaptation 
of the organisms which can contribute 
to the development of various diseases. 
Abnormally high blood concentrations of 
cortisol, known as stress hormone, lead to 
the development of a hormonal disorder 
called hyperadrenocorticism or Cushing’s 
syndrome. In the majority of cases, Cushing’s 
syndrome is diagnosed when symptoms are 
apparent, and screening endocrinological 
test confirms the existence either of increased 
cortisol production or decreased sensitivity 
of the hypothalamic-pituitary-adrenal axis 
to negative glucocorticoid feedback. In our 
research, we examined a total of 23 male 
and 7 female dogs that were suspected to 
have Cushing’s syndrome, based on history 
and clinical signs. A total of 15 male and 
5 female dogs were positive for Cushing’s 
syndrome (HAC group), whereas the 
remaining dogs were used to form non-
HAC group. Using the apparatus IDEXX 
“Vet Test 8008”, the following biochemical 
parameters were determined: glucose, urea, 
creatinine, phosphorus, calcium, total protein, 
albumin, globulin, alanine aminotransferase, 
alkaline phosphatase, bilirubin, cholesterol, 
and amylase. Regarding haematological 
parameters, the following parameters were 
investigated: erythrocytes, leukocytes, 
platelets, erythrocyte indices (MCV, MCH, 
MCHC, RDW), white blood cell count, 
haemoglobin and haematocrit, using “Laser 
cite vet lab Station” (IDEXX). No significant 
differences in haematological and biochemical 
blood parameters were noticed between 
the HAC and the non-HAC group of dogs. 
However, dogs suffering from Cushing’s 
syndrome had a higher value in the number of 
erythrocytes compared to the control group. 
The finding that has to be payed attention to 
is the difference in platelet count between the 
control group of dogs and dogs suffering from 
Cushing’s syndrome. 
Key words: dogs; Cushing’s syndrome; blood 
parameters
E. KARIĆ, A. HODŽIĆ, A. ZAHIROVIĆ, A. HRKOVIĆ-POROBIJA and H. OHRAN
VETERINARSKA STANICA 52 (4), 413-419, 2021.414
Introduction
Hyperadrenocorticism (HAC) is a 
multisystemic disorder that occurs due 
to chronically elevated blood levels of 
cortisol (Ouschan et al., 2013). This dis-
order is often referred to as Cushing’s 
syndrome, according to Harvey Cush-
ing, a Boston neurosurgeon who first 
described hyperadrenocorticism in hu-
mans in 1932 (Galac, 2010). Cushing’s 
syndrome is one of the most common 
endocrinopathies observed in small ani-
mal practice. Cushing’s syndrome usual-
ly occurs in middle-aged and older dogs 
(Carotenuto et al., 2019). Excessive levels 
of glucocorticoids cause a combination 
of physical and biochemical changes that 
have a significant impact on the quality 
of life of the animal. HAC may be the 
result of pathological excessive adreno-
corticotropic hormone (ACTH) secretion 
by a functional pituitary tumour (PDH, 
pituitary dependent hyperadrenocor-
ticism), or due to primary adrenal dis-
order (ADH, adrenal dependent HAC) 
(Behrend, 2010; Carotenuto et al., 2019). 
Oversecretion of ACTH results in bi-
lateral adrenocortical hyperplasia and 
overproduction of glucocorticoids (es-
pecially cortisol). A less common cause 
of HAC, accounting for about 15 percent 
of cases, is the overproduction of cortisol 
by adrenal tumours (Ramsey and Ristić, 
2007). Recently, HAC due to other caus-
es has also been described in dogs, but 
these appear to be rare (Carotenuto et 
al., 2019). In humans, HAC is considered 
a rare disease, with an incidence ranging 
from 0.7 to 2.4 individuals per million 
per year (Ambrosi et al., 1990; Lindholm 
et al., 2001). A recent study conducted in 
the United Kingdom reported an estimat-
ed prevalence of 0.28% for HAC (O’Neill 
et al., 2016). A significant predisposition 
to HAC has been observed in older dogs 
and some breeds, such as miniature poo-
dles, boxers and dachshunds (Carotenu-
to et al., 2019). Changes in the serum of 
dogs with Cushing’s syndrome include 
increased alkaline phosphatase (ALP) 
and alanine aminotransferase (ALT) ac-
tivity, hypercholesterolemia, and hyper-
glycaemia. The hemogram is often char-
acterized by the constellation of changes 
called „stress leukogram“. Proteinuria 
due to glomerulosclerosis is also a very 
common finding (Hodžić and Hamam-
džić, 2012). Increased ALP activity is not 
a specific parameter for Cushing’s syn-
drome, because statistically, about 10% 
of dogs with Cushing’s syndrome have 
normal ALP activity. Furthermore, any 
disease or injury that causes stress can 
lead to elevated ALP activity if it causes 
an increase in serum cortisol concentra-
tion. Increased ALP activity may also be 
a manifestation of ductile liver hyper-
plasia, a common finding in older dogs. 
High blood cortisol concentrations most 
commonly affect white blood cells caus-
ing lymphopenia, neutrophilia, monocy-
tosis, and eosinopenia. Although none of 
the abnormalities in the aforementioned 
parameters is specific to the diagnosis 
of Cushing’s syndrome, such laborato-
ry findings should direct the clinician 
to suspect Cushing’s syndrome (Gilor, 
2011). Cushing’s syndrome is associat-
ed with blood clotting disorders in dogs 
and humans. One study by a group of 
scientists showed that levels of coag-
ulation factors II, V, VII, IX, X, XI, and 
fibrinogen were significantly increased 
in dogs with Cushing’s syndrome (Jaco-
by et al., 2001). Low serum phosphorus, 
mild hypernatremia, and mild hypo-
kalaemia can sometimes be found in 
dogs with Cushing’s syndrome, but the 
clinical significance of this abnormality 
is minimal. Endocrine tests should be 
used to further confirm suspected HAC. 
Tests for hypercortisolism in dogs with 
high levels of clinical suspicion are rec-
ommended to reduce the likelihood 
of false-positive results (Sanders et al., 
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2018). The aim of this study was to ex-
pand our knowledge of HAC through 
analysis of the canine population in Bos-
nia and Herzegovina that was diagnosed 
with HAC and changes in their routine 
laboratory findings.
Materials and methods
The study was conducted on 30 
dogs suspected of having Cushing’s 
syndrome based on history and 
clinical signs. Blood sampling for 
haematological and biochemical blood 
analyses was performed at the Faculty 
of Veterinary Medicine, University 
of Sarajevo. Blood was sampled from 
each dog at the first examination and 
then biochemical and haematological 
parameters were determined. A 
comprehensive history was taken from 
the dog owner to find out as much 
information about the dog as possible, as 
well as the animals’ whereabouts, stress 
exposure, etc. The LC 320 centrifuge at 
3000 rpm/10 min was used to separate 
Table 1. Biochemical parameters of the non-HAC and HAC groups of dogs
Biochemical 
parameters Non-HAC group (N=10) HAC group (N=20) P=
Median* IQR♀ Min♂ Max♯ Median* IQR♀ Min♂ Max♯
Glucose 
(mmol/L) 4.21 5.15 1.12 8.05 5.55 1.81 1.33 30.58 0.113
Urea (mmol/L) 5.60 3.65 2.50 11.90 5.45 3.18 1.90 17.00 0.774
Creatinin 
(µmol/L) 85.00 18.25 47.00 133.00 74.50 41.00 35.00 103.00 0.234
Phosphorus 
(mmol/L) 1.52 0.62 1.17 2.55 1.28 0.25 0.78 2.77 0.134
Calcium 
(mmol/L) 2.55 0.50 1.95 3.08 2.52 0.48 2.00 3.00 0.842
Total protein 
(g/L) 74.50 22.00 60.00 102.00 68.00 9.50 59.00 77.00 0.133
Albumin (g/L) 35.00 5.00 23.00 50.00 31.50 6.25 24.00 39.00 0.122
Globulin (g/L) 41.50 15.50 31.00 55.00 36.00 5.75 30.00 44.00 0.151
ALT (U/L) 66.50 54.30 48.00 594.00 103.50 101.50 36.00 913.00 0.495
ALP (U/L) 80.00 115.80 32.00 594.00 95.00 392.00 29.00 2000.00 0.675
Bilirubin 
(µmol/L) 7.00 3.50 2.00 48.00 4.50 4.50 2.00 21.00 0.127
Cholesterol 
(mmol/L) 4.98 3.96 3.42 13.42 6.26 3.05 2.98 12.46 0.843
Amilase (U/L) 765.50 437.30 286.00 1187.00 643.00 337.00 435.00 2500.00 0.628
Sodium 
(mmol/L) 150.50 3.25 147.00 152.00 149.00 2.75 146.00 152.00 0.217
Potassium 
(mmol/L) 4.10 0.45 3.80 5.10 4.05 0.58 3.50 5.10 0.929
Chloride 
(mmol/L) 111.00 2.00 104.00 115.00 110.00 2.00 106.00 113.00 0.127
*Median – median value; ♀IQR – interquartile range; ♂Min – minimum value; ♯Max – maximum value
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the serum. Using IDEXX’s Vet test 8008 
apparatus, the following biochemical 
parameters were determined: glucose, 
urea, creatinine, phosphorus, calcium, 
total protein, albumin, globulins, 
alanine aminotransferase (ALT), 
alkaline phosphatase (ALP), bilirubin, 
cholesterol, and amylase. The 
following haematological parameters 
were determined: erythrocyte count, 
leukocyte count, platelet count, 
erythrocyte indices (MCV, MCH, 
MCHC, RDW), white blood cell count 
(WBC), haemoglobin and haematocrit, 
using a LaserCyte Vetlab Station 
(IDEXX). The test that were used for 
diagnosing Cushing’s syndrome were 
the ACTH Stimulation Test and the 
Dexamethasone Suppression Test.
Statistical analysis of the results 
was performed in Minitab 17 (Minitab, 
Inc. 2014). Initial analysis showed that 
the value distributions of most of the 
parameters tested were significantly 
different from the normal (Ryan-Joiner 
normality test) in the presence of more 
atypical (extreme) values. Therefore, 
non-parametric statistical tests were 
applied in further processing, and the 
results in tables are presented as median 
values with interquartile range (IQR), 
indicating the minimum and maximum 
values determined, or as the number of 
established cases. The Mann Whitney 
test was used to detect significance of 
differences between the two groups.
Results
Tables 1 and 2 show the biochemical 
and haematological parameters of the 
non-HAC and the HAC group of dogs. 
These parameters cannot determine 
Cushing’s syndrome, but certainly, 
provide relevant information that can 
guide the clinician to make specific tests 
for the diagnosis and treatment of the 
animal. 
Table 2. Haematological parameters of the non-HAC and HA groups of dogs
Haematological 
parameters Non-HAC group (N=10) HAC group (N=20) P=
Median* IQR♀ Min♂ Max♯ Median* IQR♀ Min♂ Max♯
RBC (x1012/L) 6.38 2.41 4.79 7.45 6.56 1.42 4.39 7.79 0.290
HCT (%) 45.65 19.25 31.20 56.00 47.30 7.20 30.80 60.70 0.523
HGB (g/dL) 14.75 3.65 12.10 19.60 15.45 1.78 9.40 21.60 0.311
MCV (fL) 70.20 5.88 64.10 75.30 71.50 7.35 63.60 79.10 0.332
MCH (pg) 24.50 4.00 20.50 27.90 23.80 313 20.50 28.30 0.261
MCHC (g/dL) 31.85 3.13 29.10 37.40 33.25 2.93 27.50 38.90 0.218
Retic(K/µL) 84.50 71.10 48.70 218.80 88.05 36.55 36.20 182.40 0.982
WBC (x109/L) 9.22 5.19 5.57 22.96 8.21 5.78 5.34 15.32 0.441
NEU (x109/L) 6.69 5.40 3.81 18.28 5.42 4.29 3.37 12.81 0.415
LYM (x109/L) 1.01 1.05 0.67 3.12 1.15 0.63 0.26 2.16 0.947
MONO (x109/L) 1.01 0.67 0.53 2.87 0.95 0.51 0.37 1.71 0.415
EOS (x109/L) 0.35 0.40 0.08 1.16 0.22 0.15 0.12 0.59 0.128
BASO (x109/L) 0.07 0.02 0.05 0.16 0.05 0.04 0.01 0.11 0.091
PLT (K/µL) 210.00 195.00 71.00 367.00 349.50 240.00 88.00 1082.00 0.006
*Median – median value; ♀IQR – interquartile range; ♂Min – minimum value; ♯Max – maximum value
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Discussion
Based on the available literature, 
no relevant data on the occurrence of 
Cushing’s syndrome in dogs in the 
territory of Bosnia and Herzegovina 
has been reported to date, although the 
disease is evident in the area. Looking at 
surrounding countries, Kiš et al. (2016) 
reported the presence of Cushing’s 
syndrome in dogs in Croatia.
Based on history and clinical 
symptoms, our study investigated 
dogs with visible changes that possibly 
suggested Cushing’s disease. A total 
of 30 dogs were analysed. Of these, 24 
dogs resided indoors and 6 dogs were 
held in yards. Purebred dogs were 
predominantly represented, of which 
7 dogs of the breed Bichon frise and 
4 Maltese dogs, whereas there were 7 
mixed breed dogs. The clinical symptoms 
of the disease are a consequence of excess 
glucocorticoids, causing atrophy of hair 
follicles and sebaceous glands, calcium 
mobilization from bones, thinning of 
blood vessel walls, intensification of 
hepatic gluconeogenesis from amino 
acids and immunodepression (Boghian 
et al., 2008). 
In our study, haematological and 
biochemical blood parameters showed 
no significant differences between the 
non-HAC and the HAC dogs (Table 1 
and Table 2). Behrend et al. (2013) found 
that blood analyses are not specific to the 
determination of Cushing’s syndrome, 
but that they may further assist in 
the easier diagnosis of the disease. 
Gilor and Graves (2011) reported that 
erythrocytosis and thrombocytosis 
are common in dogs with Cushing’s 
syndrome. In our study, no statistically 
significant difference in the number of 
erythrocytes and platelets was observed 
between the groups (Table 2). 
However, dogs with Cushing’s 
syndrome had higher erythrocyte counts 
than controls. A fact that has to be 
considered is the difference in platelet 
counts between the non-HAC group and 
the HAC group. The platelet count was 
within the physiological range in both 
groups; however, in dogs with Cushing’s 
syndrome, there was a tendency toward 
thrombocytosis, at the borderline of 
statistical significance concerning the 
non-HAC group of dogs (Table 2).
Increased ALP activity is a common 
finding in dogs with Cushing’s 
syndrome (Galac, 2010). Other common 
abnormalities include increased ALT 
activity and hyperlipidaemia, together 
with an increased amount of bile acid 
that may be present in dogs suffering 
from Cushing’s syndrome, but also in 
some liver diseases (Gilor and Graves, 
2011). Also, glucose, ALT, and ALP 
concentrations are often higher in 
Cushing’s syndrome than the reference 
values (Cho et al., 2013). This was also 
present in our study, where increased 
glucose concentrations were found in 
three, ALT in nine, and ALP in eight dogs 
positive for Cushing’s syndrome. The 
glucose, ALT, and ALP levels were almost 
twice as high in dogs within the HAC 
group when compared to the non-HAC 
group (Table 1). Likely, the differences 
in the values  of these parameters would 
also be statistically significant between 
HAC and non-HAC dogs if there were no 
large individual variation in the values  of 
these parameters.
Hypercholesterolemia and moderate 
hyperglycaemia are directly influenced 
by the level of cortisol secreted by the 
adrenal glands (Boghian et al., 2008). 
In the case of Cushing’s syndrome, 
cortisol intensifies the hepatic form of 
gluconeogenesis, starting with amino 
acids, which explains hepatic congestion, 
hepatomegaly and increased serum liver 
transaminase activity (Carlotti et al., 1998; 
Chapman et al., 2004).
Mild hypercholesterolemia and 
hyperglycaemia are also found in 
the HAC group of dogs in our study. 
Lower values of proteins, albumins, 
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and globulins in dogs with Cushing’s 
syndrome (Table 1) are probably due 
to the catabolism of structural proteins 
and amino acid utilization in the 
process of gluconeogenesis, as indicated 
by the aforementioned finding of 
mild hyperglycaemia and abdominal 
distension with muscle hypotension in 
this group of dogs.
Although the clinical significance of 
electrolyte abnormalities in diseased dogs 
is minimal, low serum phosphorus, mild 
hyponatremia, and mild hypokalaemia 
are sometimes present in dogs with 
Cushing’s syndrome (Gilor and Graves, 
2011). In our study, electrolyte values 
were within physiological limits in both 
groups, with no significant differences 
between the non-HAC and HAC group 
of dogs (Table 1).
Conclusion
To the authors’ knowledge there 
has been no relevant information on 
the occurrence of Cushing’s syndrome 
in dogs in the territory of Bosnia and 
Herzegovina. The definitive diagnosis of 
HAC cannot be based on the biochemical 
and haematological parameters, and 
specific tests need to be performed. 
More than one test is usually required 
to conclusively confirm HAC. The most 
reliable tests for diagnosing Cushing’s 
syndrome are the ACTH stimulation 
test and Low-dose dexamethasone 
suppression test. One of the tests, 
whose reliability is still at the stage of 
intensive research, is to determine the 
concentration of cortisol by analysing its 
content in the hair.
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Visoke koncentracije kortizola u krvi, 
poznatog kao hormon stresa, dovode do 
razvoja hormonalnog poremećaja koji se 
naziva hiperadrenokorticizam ili Cushingov 
sindrom. U većini slučajeva Cushingov 
sindrom dijagnosticira se kada su simptomi 
vidljivi, a endokrinološki testovi potvrde ili 
postojanje povećane proizvodnje kortizola 
ili snižene osjetljivosti osovine hipotalamus-
hipofiza-nadbubrežna žlijezda na inhibirajući 
učinak glukokortikoida. Naše je istraživanje 
obuhvatilo ukupno 23 muška i 7 ženskih pasa 
za koje se na temelju anamneze i kliničkih 
znakova sumnjalo da imaju Cushingov 
sindrom. Ukupno 15 muških i 5 ženskih pasa 
bilo je pozitivno na Cushingov sindrom (HAC 
skupina), dok su preostali psi grupirani u 
skupinu pasa bez hiperadrenokorticizma 
(non-HAC skupina). Pomoću uređaja 
IDEXX “Vet Test 8008”, određeni su sljedeći 
biokemijski parametri: glukoza, ureja, 
kreatinin, fosfor, kalcij, ukupni proteini, 
albumin, globulin, alanin aminotransferaza, 
alkalna fosfataza, bilirubin, kolesterol i 
amilaza. Od hematoloških pokazatelja, 
ispitivani su sljedeći pokazatelji: eritrociti, 
leukociti, trombociti, hematološki indeksi 
(MCV, MCH, MCHC, RDW), diferencijalna 
krvna slika, hemoglobin i hematokrit, 
korištenjem “Lasercyte Vetlab Station” 
(IDEXX). Nisu ustanovljene značajne razlike u 
hematološkim i biokemijskim pokazateljima u 
krvi između skupine pasa s dijagnosticiranim 
hiperadrenokorticizmom i bez njega. Međutim, 
psi oboljeli od Cushingovog sindroma imali 
su više vrijednosti broja eritrocita u odnosu 
na kontrolnu grupu, a ustanovljena je i razlika 
u broju trombocita između skupina koja nije 
dosegnula statističku značajnost, ali bi na nju 
trebalo obratiti pozornost.
Ključne riječi: psi, Cushingov sindrom, 
krvni pokazatelji
